Journal of Circulating Biomarkers Editor-In-Chief to Speak at 'Precision: Breast Cancer' Summit 2016

February 4, 2016

Journal of Circulating Biomarkers (JCB) Editor-in-Chief, Shidong Jia (Predicine Holding Ltd, USA), will be speaking at Precision: Breast Cancer, a Global Pharma R&D summit. The event will take place on February 23-24, 2016, in Boston (USA).

Precision: Breast Cancer’ will provide a unique networking opportunity to stakeholders across the R&D value chain to discuss key issues, and propose solutions to common challenges. Discussions will revolve around all the latest trends, including ADC/Immuno-oncology, Biomarkers/Companion Diagnostics, Antibody Constructs, Triple Negative Breast Cancer in personalized medicine - as pertaining to this disease area, through case studies from early discovery to clinical development.

Our EiC is scheduled to open Day 2 of the summit with remarks about “Precision diagnostics and medicine in breast cancer”.

To all the readers interested in this event we granted a $300 discount on the registration fee. To get the discount, please register here using the following code: NSEB668.

For more information regarding the summit, including the agenda and invited speakers, follow this link.

To read more about our JCB journal or to submit a paper, we invite you to visit the journal's homepage.